About The Scientific wisdom
Scientific wisdom is an open access publishing organization which provides a wide range of services to journals, authors, scientific communities and institutions alike. It is also an open resource platform that conducts webinars & conferences in all the major scientific disciplines including Clinical, Medical, Pharmaceutical, Engineering, Technology, Business Management and Life Sciences. Our mission is to facilitate the exchange of knowledge worldwide. To that end, we strive to attract as many viewpoints and research approaches from as many people throughout the world as possible. We think that everyone has something to say and to contribute to the most vital resource of our planet: knowledge.
JOURNALS
Our journals provide an efficacious channel for researchers, students, faculty members and other academicians in circulating quality medical knowledge throughout the world by promoting and publishing works whilst maintaining excellence in medical research. Our editorial board members greatest service is to play a supportive role, rather than a critical role. Scientific Wisdom aims towards spreading noteworthy thoughts and research information to established researchers. It allows you to network with other scholars by exchanging ideas which leads to developing valuable collaborations with researchers throughout the world.
- Journal of Psychiatry and Cognitive Sciences
- Journal of Cardiology and Atherosclerosis
- Journal of Emerging Diseases and Pathology
- Annals of Pharmaceutical Biotechnology
- Journal of Clinical Immunology and Genetics
- Clinical Trials Peer Reviewed Journals
- Journal of Integrative Oncology and Therapy
- Annals of Biomedical Research and Reviews
Webinars
Scientific wisdom is also an open resource platform that conducts webinars in all the major scientific disciplines including Clinical, Medical, Pharmaceutical, Engineering, Technology, Business Management and Life Sciences. We encourage our authors and webinar participants to get their research articles published in our open access journals. This organization is not based on the number of people. It is based on the interests, minds and abilities of everyone involved.
Abstracts
Keynote Section
- ⇒ Breast Cancer and the Perioperative Window
- ⇒ Vector-Borne Diseases: Getting Worse but New War Tactics are Now Available
- ⇒ Context aware adaptation healthcare framework for COPD disease
Michael. Retsky, University College London, USA
Keywords: Bimodal relapse pattern, Triple nega-tive breast cancer, perioperative window, non-steroidal anti-inflammatory drugs, ketorolac, business models, crowd sourcing
Abstract: This project started in 1993 when data from Italy and UK showed an unexpected bimodal pattern in patients treated with surgery. There is an early wave of relapses in the first 3 years, a minimum in the 4th year and a shallow late wave of relapses from 5 to over 10 years. My colleagues and I have been working to understand what caused this anoma-ly and what are the clinical implications. These col-leagues include surgeons, medical oncologists, anes-thesiologists and general scientists including physi-cists. We have gradually come to the conclusion that the surgery to remove a primary tumor causes sys-temic inflammation that lasts for a week. This in-flammation causes dormant cancer cells and avascu-lar micrometastases to escape dormancy, enter dis-tant organs via permeable capillaries and appear as relapses in the first 3 years post surgery. We also de-termined that perioperative NSAID ketorolac can prevent this inflammation and reduce relapses in the early years by 5 fold. This has been confirmed by 2 retrospective trials and 2 animal model studies but not yet in a prospective trial. Our main problem is the very low cost of the NSAID. The business model for cancer therapies does not work with inexpensive therapies. Also this is a disruptive innovation. For a variety of reasons, the usually grant opportunities have not worked well for us. We are now raising money using crowd sourcing methods. We intend to treat triple negative breast cancer (TNBC) at Beth Israel Deaconess Medical Center in a randomized clinical trial. We estimate that this therapy will re-duce mortality by 25 to 50% at very low cost and toxicity. Post-operative bleeding can be significantly reduced with tranexamic acid. TNBC is difficult to treat in general and there is a particular unmet need in sub-Saharan Africa and other low income commu-nities where TNBC is very common.
Biography: Michael Retsky received his PhD in exper-imental physics from University of Chicago in 1974. While working at Hewlett-Packard in Colorado Springs in 1982, a friend started an informal cancer research project since his wife was being treated for cancer. Retsky gradually became more interested in cancer research than in physics research. Over the next years, he gradually made a career change into cancer research. His first paper in oncology (Speer et al, Cancer Re-search 1984) predicted that tumor growth included periods of dormancy. He eventually became Prof of Biology at Univ of Colorado, Visiting Prof at Uni-versity of Texas, on staff of Judah Folkman at Har-vard Medical School. He was on staff at Harvard TH Chan School of Public Health. He has published over 100 papers in physics and cancer. He is currently Hon Assoc Prof at University College London.
SPARAGANO O
Keywords: Vector-borne diseases, One Health, Vaccine strategies, zoonosis, control and treatment methods
Abstract: Vector-borne diseases are presenting multiple issues for veterinarians and medical practitioners. Not only such arthropod pests are a problem in themselves (skin irritation and damage, welfare and potential secondary infections due to the arthropod bites) but many of them are carrying and transmitting many pathogens (bacteria, viruses, parasites, fungi) and create other public health, morbidity and mortality problems. Controlling such pests with insecticides or acaricides had successful effects in the past but chemical resistance is now becoming widespread and many government are seeking for more environment friendly approaches. Furthermore, developing a vaccine against these blood/lymph feeders is more challenging due to the immune battle happening inside the arthropod pest and not in the blood stream of the animal/human host. Following decades of research on arthropod vaccines only a few are still on the market today. However, new battle grounds are being explored to knock down these ectoparasites: destroying their symbionts or supporting the development of their enemies (predators or pathogens for instance) which could indirectly affect their development, reproduction and attack successes. This presentation will highlight the challenges and potential new strategies to limit if not eradicate these arthropod pests.
Biography: Prof. Olivier Sparagano received his BSc and MSc from the University of Paris VII, France, his MRes from the University Blaise Pascal, France, and his PhD from the Institut Pasteur and the University Lyon I, France. Before joining City University of Hong Kong, he was the Associate Pro Vice-Chancellor for Research at Coventry University, UK. Prior to this appointment, he was the Associate Dean for Research in the Faculty of Health and Life Sciences at Northumbria University, UK. Prof. Sparagano is a Chartered Biologist, a Fellow of the Society for Tropical Veterinary Medicine (of which he was the former President), a Fellow of the Higher Education Academy, a Fellow of the Royal Entomological Society, a Fellow of the Royal Society of Biology. He has published over 180 peer-reviewed papers and over 400 conference abstracts. He has been working on animal diseases, zoonotic pathogens and vector-borne issues for over two decades.
Hamid Mcheick, University Of Quebec At Chicoutimi UQAC, Canada
Keywords: Chronic obstructive pulmonary disease (COPD) , Public Health and Telemedicine
Abstract: Chronic obstructive pulmonary disease (COPD) is one of the most severe public health problems worldwide. Pervasive computing technology creates a new opportunity to redesign the traditional pattern of medical system. While many pervasive healthcare systems are currently found in the literature, there is little published research on the effectiveness and adaptation of these paradigms in the medical context. We designed and validated a rule-based ontology framework for COPD patients. Unlike conventional systems, this work presents a new vision of telemedicine and remote care solutions that will promote individual self-management and autonomy for COPD patients through an advanced decision-making technique. This framework organizes and manages patients’ data and information, as well as helps doctors and medical experts in diagnosing disease and taking precluding procedure to avoid exacerbation as much as possible. In this talk, I will highlight the main components of this framework and show methods to adapt it based on the context of patients. Based on the analyzed data, we found that rules accuracy estimates were 89% for monitoring vital signs, and environmental factors. The originality of the proposed approach consists in its methodology to prove the efficiency of this model in simulated examples of real-life scenarios based on collaborative data analysis, recognized by specialized medical experts. Our findings proved that dynamic thresholds can enhance existing tele monitoring systems and make a valuable contribution to identifying the health status of COPD patients. Three main conclusions can be drawn from this work. Firstly, an ontology-based system can provide a more efficient way to deal with medical data. Secondly, our framework suggests reliable recommendations. Thirdly, the results support the importance of context where it demonstrates that context variables have a strong influence on the accuracy of decisions
Biography: Dr. Hamid Mcheick is a full professor in Computer Science department at the University of Québec at Chicoutimi, Canada. He has more than 20 years of experience in both academic and industrial area. He has done his PhD in Software Engineering and Distributed System in the University of Montreal, Canada. He is working on design and adaptation of distributed and smart software applications; designing healthcare framework; and designing smart Internet of Things and edge framework. He has supervised many post-doctorate, PhD, master and bachelor students. He has nine book chapters, more than 60 research papers in international journals and more than 140 research papers in international/national conference and workshop proceedings in his credit. Dr. Mcheick has given many keynote speeches and tutorials in his research area. Dr. Mcheick has gotten many grants from governments, industrials and academics. He is a chief in editor, chair, co-chair, reviewer, member in many organizations (such as IEEE, ACM, Springer, Elsevier, Inderscience) around the world.
Oral Section
- ⇒ Plasma Medicine in Public Health
- ⇒ Pandemic Aftermath: Population social deviance, work productivity & conformity to public health measures.
- ⇒ What Can We Do in Patients with Palliative Care that Can Improve Their Quality of Life or Even Cure Them?
- ⇒ Ten public health strategies to control the Covid-19 pandemic: the Saudi Experience
- ⇒ Autologous Peripheral Blood ( APB ) Stem cell and plasma against the Sars-CoV-2 lethal contagious infections
- ⇒ Cystatin C in patients with coronary artery disease
Deborah Black
Keywords: Plasma Medicine Device, Plasma Technology and Public Health
Abstract: This mature plasma medicine device uses corona like cold air plasma technology, which has been designed for safe domestic and hospital use. It is the only one of its kind globally, first invented in 1967 by Australian. Citizen Scientist Mr Joshua Shaw and enhanced by his protégé Deborah Black. Pulsed electrical fields of reactive and non-reactive, neutral and negatively charged air ion species are emitted through proprietary quantum portals with variable dosages of power and controlled frequencies which are fully regulated according to the health condition, and other variable factors of the patient for systemic biological benefits. Vibrating emissions and the proprietary safe electrical and magnetic fields created, primarily interact with the respiratory system enhancing immune responses of phagocytes, meliorating the REDOX biology of the body and neurohormonal disturbances in a naturally selective manner, whilst working as a ‘systematic selective adaptogen®’ for the entire human body systems. The device has also been used for chronic wound healing in diabetic feet plus breast and other cancers. The special air species are both ingestible and transdermal. In Australia, this medical device is TGA registered and has had a long successful market history, reputation and process of Research & Development in humans over 53 years. It is medically registered in Australia and the UK for the treatment and prevention of virus, bacteria and other pathogen related respiratory conditions including colds and flu, allergies, hormones, chronic fatigue, depression, immune system recovery, assist medicine and vitamin absorption plus an array of additional medically allowable claims. Claims which were registered upon the support of safe results, no adverse health events and no recalls in human use. The purpose of this presentation is to show the many and varied impressive and safe results achieved in over 1 Million humans, in an effort to increase global collaboration efforts and scientific knowledge of its unique active mechanisms with modern science for the benefits of all humanity. Patented and Trademarked ©.
Biography: Debbie is the recognised World Expert in Corona Cold Air Plasma Medicine with Quantum Physics and Roach energy for biological benefits across the systems of the human body. She owns the patent for advancing the sciences of her medical device, now known as a “systemic selective adaptogen” and has an extensive record of results in humans across a lot of medical conditions. 97% of her patients no longer suffer colds and flu of any mutation. She has almost 10 years’ experience as an Independent Scientist working across 38 multidisciplinary scientific fields; 16 years of academic training and a 38 year career as a Chief Executive across 17 countries including 9.5 years in Fortune 100 companies including International diplomacy. She recognises Mr Joshua Shaw (1938-2019) the original inventor and her mentor for his life’s work and passion towards human health. She calls herself a ‘humanitarian on a mission to improve global health.
R.M. Boylan, Researcher & Healthcare professional, Canada.
Keywords: Covid Pandemic and Public Health
Abstract: Abraham Maslow demonstrated that “without the transcendent and the transpersonal, we get sick, violent, and nihilistic, or else hopeless and apathetic. We need something bigger than we are to be awed by and to commit ourselves to in a new, naturalistic, empirical and non-churchly sense.” This research compared Maslow’s 6-stage hierarchy of needs to Jane Loevinger’s framework for ego development and Loevinger’s corresponding instrument for assessing the level of human development an individual and/or leader is at. Loevinger’s instrument on ego development assesses personality traits, moral development and cognitive complexity. Using the Kepner-Tregoe decision analysis instrument, R.M. reviewed the merits of both models for identifying the level of stage progression of a leader at a given time point and/or a human being. In this context, the research is being extrapolated in consideration of the aftermath consequences of the pandemic with insights & considerations for population health, human flourishing, morbidity, mortality & social deviance. In this presentation R.M. presents the application of Maslow & Jane Loevinger’s research to the pandemic in relation to human conformity to public health measures, social deviance, workplace productivity & population vulnerability. RM elucidates the levels of human behavioral issues to consider that could be expected based on populations at risk, vulnerable groups and potential outlier groups that may retaliate in the next 6-12 months using researched constructs. Specifically, considering the plausible emergence of further lockdown measures if variants emerge in 3-6 months. R.M. equally discusses the research on human flourishing and opportunities that leaders may undertake to inspire populations to incite peace, workforce productivity and social order.
Biography: Rose-Marie Boylan, BSc. M.A. is a Dietitian by trade. She has worked across 6 of the largest pharmaceutical companies for over 27 years, and 4 smaller organizations. She has specialized in patient access to medicines, patient reported outcomes, health & conomics, policy influence for patient self-sovereignty. In parallel, Rose-Marie has researched for over 13 years social, civil and political cost-consequence & cost-benefits of psychiatry, transpersonal psychology & human flourishing in violence survivors. This includes a cost-consequence model. She completed her Masters in 2009 in Leadership Studies with research on the optimum levels that humans can attain in a life time for developing the highest levels of moral, emotional & cognitive intelligence through self-actualization & post-traumatic growth. Leveraging the research of Abraham Maslow & Jane Loevinger on ego development she developed a model which defines mind health vs. psychopathologies. Additionally for 13 years Rose-Marie studied mind-body medicine with the likes of Dr. Herbert Benson from Harvard’s Mind Body Institute, Jon Kabat- Zin, Saki Santorelli from the University of Massachusetts School of Preventive & Behavioral Medicine. Additionally researching all forms of meditation, therapeutic & mindfulness yoga teacher trainings which she has taught to trauma survivors & professionals in crisis.
Huang Wei Ling, Medical Acupuncture and Pain Management Clinic, Brazil.
Keywords: Palliative care, Cancer, Diet, Energy, Traditional Chinese Medicine, Chakras, Homeopathy and Hippocrates.
Abstract:
Statement of the Problem: Palliative care is a relative new specialty recognized by some countries and aims to provide cancer´s patients end of care. And it is defined by the World Health Organization as the care of patients that are with life-threatening illness, with early detection and preventing measurements to reduce their morbidity and mortality. According to traditional Chinese medicine, cancer came from energy deficiency and Heat retention. And through the author’s studies, chronic patients have energies deficiencies in the chakras’ energy centers (diabetes, hypertension, myocardial infarction, cancer, etc). Purpose: to demonstrate that patient in palliative care has energy imbalances in the root level (energy imbalances) and the treatment of all this disharmonies and deficiencies are important to recover from their diseases, even cancer patients.
Methods: Through 4 cases reports of cancer patients (thyroid, pap smear grade IV, breast cancer, prostate cancer, Lung cancer), all of them with chakras ´energies deficient in energy. The treatment using Chinese dietary counseling, auricular acupuncture with apex ear bloodletting and homeopathies medications according to the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine were used.
Results: All patients improved their quality of life treating their energy deficiencies and the first two patients cured from their cancer diseases only using this kind of approach.
Conclusion: The conclusion of this study is that patients with cancer and all chronic disease have energy deficiencies in the chakras’ energy centers and the treatment using Chinese dietary counseling, auricular acupuncture with apex ear bloodletting and replenishing the chakras’ energy centers with homeopathies medications according to the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine are very important to treat the root of all the problems of these patients and not just treating the symptoms
Biography: Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.Author of the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine. Author of more than 40 publications about treatment of variety of diseases rebalancing the internal energy using Hippocrates thoughts.
Areej Abdul Ghani AlFattani, Biostatistics, Epidemiology and Scientific Computing Department
King Faisal Specialist Hospital and Research Center, Saudi Arabia.
Keywords: Covid_19, Saudi Arabia, Pandemic, Experience, Strategies, Control and Precautions
Abstract:
Introduction: In the time of coronavirus, the Kingdom of Saudi Arabia is of specific importance because of its strategic, religious, economic and geographical roles in the world. The Saudi experience has demonstrated success, with a comprehensive multisectoral plan to counter the Covid-19 pandemic.
Methods: In this article, we reviewed all public health -related policy decisions from Saudi Ministry of Health, and other governmental and private bodies that contributed to limit covid-19 consequences. We constructed an epidemiological flattening curve to show comparison of Saudi Arabia’s performance with some other countries.
Results: The ten effective strategies were: quarantine and travel restriction, expanded serological screening, apply face covering and social distance, hospital preparedness, use of artificial intelligence, remove slums, cancel Hajj season, rescue the economy, public assurance and fair vaccine distribution. As well we shed light on some challenges.
Conclusion: The government of Saudi Arabia showed a top level of responsibility that prioritized the safety and well-being of its citizens and residents. Rapid early response to the pandemic warnings, extensive experience in previous epidemics and in mass gathering medicine, wise management of healthcare resources, and unprecedent harmonization of governmental and private sectors were significant factors for this success.
Biography: Experienced Clinical Research Professional with a demonstrated history of working in hospitals primary health care centres. Passion in education and training. Skilled in Epidemiology, research methodology, scientific writing, biostatistics, and research project management. Strong research professional potentials with a Diploma focused in Epidemiology & Medical Statistics from Liverpool School of Tropical Medicine. Solid background on clinical trials design, management and execution from John Hopkins Bloomberg school of public health. SOCRA certified. Board member of Saudi Epidemiology Society.
Kieu C.D. Nguyen, American Stem Cells Hospital and Human Stem Cells Institute, Vietnam.
Keywords: COVID-19, Sars-CoV-2, APB Stemcell, Plasma and Human Immune System
Abstract: Acute respiratory infections are probably one of the most common issues of healthcare systems and should be considered a worldwide cause of morbidity and mortality. Since the end of 2019 coronavirus disease (COVID-19) consequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly affected millions of people world-wide. According to data elderly and adults with underlying diseases are at higher risk of Sars-Cov-2 infection. Severe form of the disease with severe acute respiratory infection, multi-organ failure (MOF) and death still present multiple obscure aspects that need to be unveiled. Based on the auxiliary role of Autologus Peripheral Blood (APB) stem cells and plasma therapy and regenerative medicine approaches in the treatment of several life-threatening diseases, effective and safety strategy for improving subjects with severe acute respiratory infections caused by the 2019 novel coronavirus. These case reports focuses on the success of APB stem cells and plasma to reduce inflammatory processes of acute respiratory infections and mortality caused by COVID-19.
Biography: Kieu CD Nguyen is working in the Department of Human International Medical Center at Tan Tao University, Vietnam. Kieu CD Nguyen main areas of research interest are in the fields of Blood Stem Cells.
Mohamed Wasfy Mohamed
Keywords: Cystatin C, Coronary Artery Disease (CAD), Chronic Kidney Disease (CKD) and Public Health
Abstract:
Background: Cystatin C, a marker for early stage chronic kidney dysfunction, mediates the pathogenesis of cardiovascular diseases.
Objectives: To assess the relation between level of serum Cystatin C and severity of coronary artery disease (CAD) in patients without chronic kidney disease (CKD).
Patients and Methods: In this cross-sectional study, we included 80 patients with CAD divided in two groups (group I with acute coronary artery disease and group II with chronic stable coronary artery disease) 40 patients each and acquired their demographic characteristics, medical histories, and listings of the concurrent medications they were taking. All patients with CAD underwent ECG, echocardiography, coronary angiography, serum Cystatin C level, cardiac enzymes and other routine laboratory tests.
Results: As regard demographic data and comorbidities there was no significant difference between the two groups as regard gender, diabetes mellitus, hypertension or smoking. Also, As regard level of serum Cystatin C, the mean and SD in 1 vessel affection was 0.92±0.07 while in 2 vessels affection was 1.07±0.13 and 3 vessels affection was 1.41±0.05 with (P< 0.01). Finally, there was a highly significant difference as regard Cystatin C level with mean and SD 1.21±0.18 in ST-segment elevation MI while mean and SD was 0.96±0.09 in Non ST-segment MI or unstable angina with (P< 0.01). There was a statistically significant correlation between level of Cystatin C and severity of CAD (p < 0.05).
Conclusion: Serum cystatin C has a significant effect on the severity of coronary artery disease (CAD) , being higher in patients with 3 vessels disease and severe CAD.
Biography: Dr. Mohamed Wasfy has his expertise in evaluation and passion in improving the health and wellbeing. His open and contextual evaluation model based on responsive constructivists creates new pathways for improving healthcare. He is a cardiology specialist from Shebin El-Kom teaching hospital and post-graduate studies from Menoufia University School of Medicine.